The pharmacokinetics of GLP-1 receptor agonists create windows of peak activity, troughs of reduced effect, and transition periods where side effects hit hardest
Immunomodulation effects are currently thought to have principal roles in renoprotective effect of GLP-1RAs
Significant weight changeswhether loss or gaincan disrupt the delicate hormonal balance that regulates the menstrual cycle
Purity tested Endotoxin tested Heavy metals tested Vasoactive Intestinal Peptide, a 28-amino-acid neuropeptide with broad functions spanning vasodilation, immune modulation, neuroprotection, and circadian rhythm regulation
For weight management, it is approved for adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, as an adjunct to a reduced-calorie diet and increased physical activity
Diabetes 45 , 832835 (1996)